This brand name is authorized in Mexico
The drug CYNOPLUS contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Levothyroxine
UNII 9J765S329G - LEVOTHYROXINE SODIUM
|
|
Levothyroxine sodium is used for the treatment of hypothyroidism. The chief action of levothyroxine is to increase the rate of cell metabolism. |
|
2
Liothyronine
UNII GCA9VV7D2N - LIOTHYRONINE SODIUM
|
|
Liothyronine sodium is a naturally occurring thyroid hormone. The biological action of liothyronine sodium is quantitatively similar to that of levothyroxine sodium. |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 81906 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
